MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in COVID-19 patients? |
| A. | Sun Pharma |
| B. | Zydus Cadila Pharmaceuticals |
| C. | Cipla |
| D. | Glenmark Pharmaceuticals |
| E. | Torrent Pharmaceuticals |
| Answer» C. Cipla | |